IP Library Granted Patent US 8,357,403
Granted Patent B2
US 8,357,403 · App. 12/206,508 · Granted Jan 22, 2013

Placental tissue grafts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,357,403
App. No.
12/206,508
Granted
Jan 22, 2013
Kind
B2
Abstract

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

Claims (18)

1. A method for preparing a tissue graft, comprising the steps:

(a) processing a placenta comprising an amnion membrane layer and a chorion tissue layer to separate the chorion tissue layer from the amnion layer, wherein the amnion membrane layer comprises a first side comprising epithelial cells adjacent to a basement membrane and a second side comprising a jelly-like fibroblast cellular layer;

(b) removing substantially all of the epithelial cells to expose the basement membrane of the amnion membrane layer while maintaining the jelly-like fibroblast cellular layer to produce a first membrane;

(c) laminating a second amnion membrane layer onto the first amnion membrane layer, wherein the epithelial cells have not been removed from the first side of the second amnion membrane, and wherein the fibroblast layer of the first amnion membrane layer is adjacent to the epithelial layer of the second amnion membrane layer; and

(d) optionally laminating one or more additional membranes on the first or second amnion membrane layers to produce a layered tissue graft.

2. The method of claim 1 , further comprising, after step (a) but prior to step (b), soaking the amniotic membrane layer in an antibiotic solution.

3. The method of claim 1 , further comprising the step of rinsing the amniotic membrane layer to remove the antibiotic solution.

4. The method of claim 1 , further comprising, after step (a) but prior to step (b), physically cleaning the amniotic membrane to remove blood clots and other contaminates.

5. The method of claim 1 , wherein step (b) comprises scraping the epithelium layer to substantially remove the epithelium cells.

6. The method of claim 1 , wherein the one or more additional membranes comprises amnion, chorion, allograft pericardium, allograft acelluar dermis, amniotic membrane, Wharton's jelly, purified xenograft Type-1 collagen, biocellulose polymers or copolymers, biocompatible synthetic polymer or copolymer films, purified small intestinal submucosa, bladder acellular matrix, cadaveric fasia, or any combination thereof.

7. The method of claim 1 , wherein the one or more additional membranes comprises chorion, amnion, or a combination thereof.

8. The method of claim 1 , wherein the placenta is cleaned prior to step (a).

9. The method of claim 1 , further comprising:

(d) mounting the layered tissue graft onto a surface of a drying fixture; and

(e) dehydrating the layered tissue graft.

10. The method of claim 9 , wherein the basement membrane of the first membrane is adjacent to the surface of the drying fixture.

11. The method of claim 1 , wherein the first membrane and the one or more additional membrane are laminated by fibrin glue or gelatin.

12. The method of claim 1 , wherein the first membrane and the one or more additional membrane are laminated by a photochemical technique or suturing.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2014
From: SNOASIS MEDICAL, INC.
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 033451/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2014
From: TOFE, ROBERT
To: SNOASIS MEDICAL, INC.
Reel/Frame 033427/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2012
From: SURGICAL BIOLOGICS, LLC
To: MIMEDX GROUP, INC.
Reel/Frame 029169/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2012
From: DANIEL, JOHN; TOFE, ROBERT; SPENCER, RANDALL; RUSSO, JOHN
To: SURGICAL BIOLOGICS, LLC
Reel/Frame 029169/0758 →